Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
P. aeruginosa, a type of bacteria, is increasingly drug-resistant, and there's no vaccine against it. But it has a recently discovered Achilles heel.
Scientists have modified immune cells, imbuing them with the ability to not only detect, but reveal, the presence of a tumor.
Cracking the crystal structure of a protein complex centered around a major immune signaling protein, interferon-gamma, may speed its medical use.
A small change in how patients learn to think about side effects of a food allergy treatment greatly reduces their anxiety, Stanford researchers found.
A new blood test measures the DNA fragments of lung transplant donors in the blood of recipients, in hopes of preventing organ rejection and saving lives.
Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.
New research has confirmed that an antigen in some variants of the flu virus and vaccine can, in rare cases, trigger an autoimmune response leading to narcolepsy.
About 31 million U.S. adults have food allergies, nearly half of which develop after age 18, findings that surprised food allergy experts.
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
In this In the Spotlight Q&A, Yaw Shin Ooi, a postdoctoral fellow in microbiology and immunology shares his thoughts on science, Buddha, and more.
With age comes wisdom: mostly true. But a new study helps explain why one part of us - our immune system - gets decidedly dumber with age.
Much of what we know about the immune system comes from experiments conducted on mice. But lab mice are not little human beings. The two species are separated by both physiology and lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.
Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.
Kenneth Gibbs, Jr., is using his graduate degree in immunology to improve graduate education nationally — he shares more in this Q&A.
The ratio between a certain types of immune cells is able to predict whether latent TB will shift into an active infection, new research has found.
